These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35785215)

  • 1. A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy.
    Zhou Z; Han X; Sun D; Liang Z; Wu W; Ju H
    Front Oncol; 2022; 12():855915. PubMed ID: 35785215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
    Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
    Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
    Front Immunol; 2022; 13():831848. PubMed ID: 35320931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme.
    Zhu J; Hao J; Ma Q; Shi T; Wang S; Yan J; Chen R; Xu D; Jiang Y; Zhang J; Li J
    Front Oncol; 2021; 11():661040. PubMed ID: 33937076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
    Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
    J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 Protein Expression Is Associated With Good Clinical Outcomes and Nomogram for Prediction of Disease Free Survival and Overall Survival in Breast Cancer Patients Received Neoadjuvant Chemotherapy.
    Chen L; Huang S; Liu Q; Kong X; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
    Front Immunol; 2022; 13():849468. PubMed ID: 35669769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a nomogram based on body composition analysis of quantitative computed tomography combined with clinical prognostic factors to predict disease-free survival after surgery and adjuvant chemotherapy in patients with gastric cancer.
    Wei L; Fu B; Bo J; Jia H; Sun M; Jiang X; Wang T; Wang P; Dong J
    Quant Imaging Med Surg; 2023 Dec; 13(12):8489-8503. PubMed ID: 38106291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
    Zhu M; Liang C; Zhang F; Zhu L; Chen D
    Front Oncol; 2021; 11():690336. PubMed ID: 34745934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases.
    Bohlok A; Inchiostro L; Lucidi V; Vankerckhove S; Hendlisz A; Van Laethem JL; Craciun L; Demetter P; Larsimont D; Dirix L; Vermeulen P; Donckier V
    Eur J Surg Oncol; 2023 Jan; 49(1):217-224. PubMed ID: 36031469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
    Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
    EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
    Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
    Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy.
    Wei S; Han Y; Zeng H; Ye S; Cheng J; Chai F; Wei J; Zhang J; Hong N; Bao Y; Zhou J; Ye Y; Meng X; Zhou Y; Deng Y; Qiu M; Tian J; Wang Y
    Eur J Radiol; 2021 Sep; 142():109863. PubMed ID: 34343846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram predicting the cancer-specific survival of early-onset colorectal cancer patients with synchronous liver metastasis: a population-based study.
    Ding X; Yang X; Wu D; Huang Y; Dai Y; Li J; Chang W; Chi M; Tian S
    Int J Colorectal Dis; 2022 Jun; 37(6):1309-1319. PubMed ID: 35524790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy.
    Chen S; Tang Y; Li N; Jiang J; Jiang L; Chen B; Fang H; Qi S; Hao J; Lu N; Wang S; Song Y; Liu Y; Li Y; Jin J
    Front Oncol; 2021; 11():784156. PubMed ID: 34869040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study.
    Meyer Y; Bohlok A; Höppener D; Galjart B; Doukas M; Grünhagen DJ; Labar A; Lucidi V; Vermeulen PB; Verhoef C; Donckier V
    Clin Exp Metastasis; 2022 Jun; 39(3):433-442. PubMed ID: 35124739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative nomogram to predict survival following colorectal cancer liver metastasis simultaneous resection.
    Meng Q; Zheng N; Wen R; Sui J; Zhang W
    J Gastrointest Oncol; 2021 Apr; 12(2):556-567. PubMed ID: 34012649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a nomogram for predicting survival of breast cancer patients with neoadjuvant chemotherapy: a dynamic analysis for systemic inflammation response index.
    Huang W; Xiong Z; Zhong W; Zhang C; Feng J; Wang X
    Gland Surg; 2023 Nov; 12(11):1459-1474. PubMed ID: 38107499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.